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Ly6Chi monocytes play diverse roles in
tissue immunity, but how this diversity of
function is imposed remains poorly
understood. Askenase and colleagues
demonstrate that during infection, NK
cells prime monocytes for regulatory
function prior to bone marrow egress in
response to systemic signals emanating
from the infected tissue.
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Tissue-infiltrating Ly6Chi monocytes play diverse
roles in immunity, ranging frompathogen killing to im-
mune regulation.Howandwhere thisdiversityof func-
tion is imposed remains poorly understood. Here we
show that during acute gastrointestinal infection,
priming of monocytes for regulatory function pre-
ceded systemic inflammation and was initiated prior
to bone marrow egress. Notably, natural killer (NK)
cell-derived IFN-g promoted a regulatory program in
monocyte progenitors during development. Early
bonemarrowNKcell activationwascontrolledby sys-
temic interleukin-12 (IL-12) producedbyBatf3-depen-
dent dendritic cells (DCs) in the mucosal-associated
lymphoid tissue (MALT). This work challenges the
paradigm that monocyte function is dominantly
imposed by local signals after tissue recruitment,
and instead proposes a sequential model of differ-
entiation in which monocytes are pre-emptively
educated during development in the bone marrow to
promote their tissue-specific function.
INTRODUCTION
Tissue inflammation induces the rapid recruitment of circu-
lating myeloid cells that can both generate inflammatory
responses to protect against infection as well as mediate
regulatory responses and tissue repair. Ly6Chi monocytes in
particular can perform multiple roles upon tissue recruitment,
and the differentiation and effector function of these cells
can be shaped by the local tissue environment, both at steady
state and during inflammation (Bain et al., 2013; Tamoutoun-
our et al., 2013; Zigmond et al., 2012). For instance, local
acquisition of regulatory mediators, such as interleukin-101130 Immunity 42, 1130–1142, June 16, 2015 ª2015 Elsevier Inc.(IL-10), by recruited monocytes has been described in the
healthy gut and inflamed skin, as well as during muscle repair
(Arnold et al., 2007; Bain et al., 2013; Egawa et al., 2013), and
Ly6Chi monocytes can give rise to immunosuppressive tumor-
associated macrophages in cancer (Franklin et al., 2014).
From these studies, a paradigm has emerged proposing that
local tissue signals are largely responsible for the acquisition
of appropriate function and fate of Ly6Chi monocytes after
tissue entry (Bain and Mowat, 2014; Ingersoll et al., 2011; Ser-
bina et al., 2008).
Increased bone marrow (BM) output of inflammatory cells,
known as ‘‘emergency myelopoiesis,’’ is a critical feature of
the host response to injury or infection. This process can be
driven by systemic inflammatory factors and/or pathogen-
derived products acting on precursor cells (Takizawa et al.,
2012). Long-term changes to monocyte function favoring micro-
bicidal potential after infection have been recently documented
in a process termed ‘‘trained immunity’’ (Cheng et al., 2014;
Quintin et al., 2012). It remains unknown, however, whether in
defined inflammatory settings, discrete signals could alter
monocyte function during development prior to the onset of sys-
temic inflammation.
Early education of monocytes might be particularly important
for controlling immune responses at highly reactive sites such
as the gut. In this context, we previously identified a dual role
for Ly6Chi monocytes during acute intestinal infection with
Toxoplasma gondii in limiting responses to commensal mi-
crobes and preventing lethal immunopathology (Grainger
et al., 2013). Here, we used this model to examine how and
where monocytes become primed for regulatory functions.
We found that, contrary to the prevailing paradigm, the capac-
ity of Ly6Chi monocytes to respond to microbial stimuli can be
altered during their development and prior to BM egress. These
results reveal that the functional diversity of monocytes might
be imprinted early in development and uncover a role for
BM innate lymphoid cells in altering hematopoiesis in order to
generate effector cells optimally programmed to control tis-
sue-specific immunity.
RESULTS
Systemic Alteration of Ly6Chi Monocytes prior to Tissue
Recruitment
After per-oral infection with T. gondii, Ly6Chi monocytes play an
important role in protecting against the pathogen (Dunay et al.,
2008), as well as regulating pathologic responses toward the
microbiota via prostaglandin E2 (PGE2) production (Grainger
et al., 2013). We assessed whether the potential for regulatory
function was imposed by signals in the mucosal environment
or acquired prior to tissue recruitment. To this end, we first
explored the possibility that functional alterations to monocytes
were coupled with a distinct surface phenotype. As previously
described (Grainger et al., 2013), all Ly6Chi monocytes from
T. gondii-infected small intestine lamina propria (SILP) ex-
pressed MHCII (Figures 1A and S1A). Moreover, in contrast to
their naive counterparts, Ly6Chi monocytes from infected mice
expressed high levels of stem cell antigen 1 (Sca-1) (Figure 1A).
However, unlike monocytes described in other acute inflam-
matory settings (Tamoutounour et al., 2013; Zigmond et al.,
2012), Ly6Chi monocytes did not express fractalkine receptor
(CX3CR1) (Figure 1A). Thus, monocyte regulatory properties in
the gut are associated with a previously un-described pheno-
typic signature, an observation that provided us with the oppor-
tunity to track when and where monocyte regulatory priming
occurred.
This phenotype was detectable in the blood as early as day 4
after the infection and was adopted by all Ly6Chi monocytes by
day 6 (Figures 1B, S1B, and S1C). In addition to Ly6Chi mono-
cytes, the blood is home to a population of patrolling Ly6Clo
monocytes important for repair andmaintenance of the endothe-
lium (Carlin et al., 2013). Concurrent with changes to their pheno-
type, the Ly6Chi monocyte subset rapidly became the dominant
monocyte population present in the circulation during infection
(Figure 1C).
As in the gut, these phenotypic changes in the blood
compartment were associated with the acquisition of regulatory
responses. The potential to express IL-10 was increased in
circulating Ly6Chi monocytes after infection and Ly6Chi mono-
cytes isolated from the blood of infected mice produced greater
quantities of PGE2 and IL-10 upon stimulation with E. coli lysate
(Figures 1D, 1E, and S1D). E. coli lysate represents a relevant
source of stimulation for monocytes homing to the gut, as shown
by the fact that during acute mucosal infections, the gut be-
comes dominated by g-proteobacteria such as E. coli that
contribute to inflammation (Heimesaat et al., 2006; Molloy
et al., 2013). In contrast to granulocyte colony stimulating factor
(G-CSF)-induced regulatory monocytes (D’Aveni et al., 2015),
acquisition of anti-inflammatory potential by monocytes after
infection was not associated with expression of CD34 (Fig-
ure S1E). As in the gut, monocytes in the blood maintained their
effector potential upon acquisition of regulatory function, pro-
ducing TNF-a upon stimulation (Figure 1E).
Surprisingly, the onset of systemic alterations to Ly6Chi mono-
cytes preceded monocyte recruitment to the SILP, increases in
systemic IFN-gorTNF-a, anddetectable intestinalpathology (Fig-
ures 1F, 1G, and S1F–S1H). Additionally, these changes were not
the consequence of parasite dissemination from the MALT
(Figure S1I). Thus, after infection, early phenotypic alterations tomonocytes are associated with profound changes to their func-
tion in both the target tissue and the blood compartment.
IFN-g Remodels the Blood Monocyte Compartment
during Infection
We next assessed whether acquisition of the MHCII+Sca-
1+CX3CR1 phenotype by monocytes was a common response
to infection. To this end, mice were infected with Yersinia pseu-
dotuberculosis and Plasmodium yoelii, pathogens known to
induce type 1 immune responses (Doolan and Hoffman, 1999;
Logsdon andMecsas, 2006). In both settings, Ly6Chi monocytes
acquired a phenotype similar to that observed during T. gondii
infection and became the dominant blood monocyte subset
(Figures 2A and 2B). This observation supported the idea that
monocyte regulatory priming was probably driven by a canonical
mediator of host defense employed during these responses,
rather than by interaction with a specific pathogen. Indeed, after
injection of recombinant IFN-g for 3 days, blood Ly6Chi mono-
cytes ubiquitously expressed Sca-1 and MHCII and demon-
strated decreased expression of CX3CR1 (Figure 2C). Moreover,
IFN-g increased the proportion of circulating Ly6Chi monocytes
(Figure 2D). Conversely, blockade of IFN-g during T. gondii infec-
tion prevented these phenotypic and subset alterations (Figures
2E and 2F).
We next addressed whether this phenomenon was the conse-
quence of cell-intrinsic or -extrinsic responses to IFN-g. To this
end, we generated mixed BM chimeras with WT cells and
cells lacking IFN-g receptor (Ifngr1/) that were subsequently
infected with T. gondii. Changes tomonocyte surface phenotype
as well as alterations in proportion of Ly6Chi monocytes were
dependent on cell-intrinsic IFN-g receptor signaling (Figures
2G and 2H).
Ly6Chi Monocytes Are Functionally Primed in the Bone
Marrow
Our results thus far supported the idea that monocytes can
be primed for regulatory function prior to BM egress. To explore
this possibility, Ly6Chi monocytes were isolated from BM at day
5 post-infection and stimulated ex vivo with various bacterial
or parasite-derived ligands. Even at this early time point, BM
monocytes had already acquired enhanced capacity to produce
PGE2 in response to several bacterial ligands, but not parasite li-
gands, compared to cells isolated from naive mice (Figure 3A).
Enhanced PGE2 production by BM monocytes was still detect-
able at 24 days post-infection (Figure 3B), past the acute phase
of disease (Grainger et al., 2013; Molloy et al., 2013).
Acquisition of this regulatory function by BM monocytes was
dependent on signaling by IFN-g, as shownby the fact that in vivo
blockade of IFN-g during infection returned PGE2 production to
baseline levels (Figure 3C). Furthermore, administration of IFN-g
to naive mice was sufficient to drive increased PGE2 production
by BM monocytes, and ex vivo IFN-g treatment of monocytes
isolated from naive mice enhanced PGE2 production (Figures
3D and 3E).
To more comprehensively explore the early consequences of
infection on the function of monocytes, sorted BM Ly6Chi mono-
cytes from naive or day 5 T. gondii-infected animals were
cultured in the presence or absence of LPS, and mRNA expres-
sion of 490 myeloid genes was assessed with the NanoStringImmunity 42, 1130–1142, June 16, 2015 ª2015 Elsevier Inc. 1131
Figure 1. Monocytes Are Educated prior to Tissue Entry during Infection
CX3CR1-GFP mice were infected per-orally with T. gondii.
(A) Flow-cytometric analysis of Ly6Chi monocytes (Mo) present in the small intestinal lamina propria (SILP) of naive animals or at day 8 post-infection (p.i.).
(B) Phenotype of blood Ly6Chi monocytes at defined time points p.i. as measured by flow cytometry.
(C) Frequency of blood Ly6Chi monocytes within the total blood monocyte compartment.
(D) Ex vivo PGE2 production by Ly6C
hi monocytes sorted from the blood of naive or day 8 infected mice and cultured in the presence or absence of E. coli lysate.
(E) IL-10 and TNF-a production by blood Ly6Chi monocytes from naive and day 8 T. gondii-infected animals cultured in the presence or absence of E. coli lysate.
(F) Accumulation of monocytes in the SILP.
(G) Serum levels of IFN-g and TNF-a in infected mice. Dots represent individual animals.
Error bars represent standard deviation. Data are representative of at least two independent experiments, n = 3–6 per group. Statistical comparisons were
performed with one-way ANOVA or unpaired Student’s t test adjusted for multiple comparisons. **p < 0.01, ***p < 0.001. See also Figure S1.platform. Principal-component analysis revealed that mono-
cytes from T. gondii-infected animals demonstrated a transcrip-
tional program distinct from those isolated from naive controls,
when cultured in media alone as well as upon LPS stimulation
(Figure 3F, Table S1).1132 Immunity 42, 1130–1142, June 16, 2015 ª2015 Elsevier Inc.We next compared the gene expression of untreated BM
Ly6Chi monocytes from naive animals to that of each of the other
groups (naive + LPS stimulated, T. gondii-infected untreated,
T. gondii-infected + LPS stimulated) (Figure 3G). Our analysis
revealed that in untreated monocytes from infected animals, a
greater than 2-fold change in expression of 33 genes was
observed (Figure 3G, purple circle). Moreover, after infection,
the responsiveness of BM monocytes to LPS stimulation was
dramatically altered. In total, 88 common genes were differen-
tially expressed upon LPS stimulation in monocytes from both
naive and infected animals, but an additional 30 genes were
altered in expression only in monocytes from infected animals
(Figures 3G and 3H).
In support of our functional read out, expression of Ptgs2, the
gene that encodes COX-2, a key enzyme controlling PGE2 pro-
duction during inflammation (Ricciotti and FitzGerald, 2011),
was induced in response to LPS stimulation in monocytes from
infectedmice (Figure 3H). Further supporting the idea thatmono-
cytes were primed for increased regulatory function prior to
BM egress, gene expression ofCd200, which encodes a surface
protein that suppresses innate immune cell function (Snelgrove
et al., 2008), and Socs3, which encodes a negative regulator
of inflammatory cytokine signaling (Carow and Rottenberg,
2014), was also increased. Monocytes from infected mice also
augmented the expression of genes encoding pro-inflammatory
factors upon LPS stimulation, including IL-1b and IL-12, sug-
gesting a generally increased responsiveness to bacterial li-
gands. These results imply that early during infection and prior
to BM egress, monocytes are primed for both regulatory and
effector responses after exposure to bacterial stimuli.
IFN-gControls the Transcriptional ProgramofMonocyte
Progenitors
Monocytes are constitutively generated in the BM, developing
through a series of well-defined stages including the granulocyte
monocyte precursor (GMP), monocyte dendritic cell precursor
(MDP), and themore recently described commonmonocyte pro-
genitor (cMoP) (Fogg et al., 2006; Hettinger et al., 2013). Notably,
we found that early during the infection, cMoPs and BM mono-
cytes began to acquire the distinct phenotype associated with
acquisition of regulatory function (Figures 4A, S2A, and S2B).
These phenotypic changes persisted after resolution of the acute
phase of the infection (Figures S2C–S2E).
We next assessed how mucosal infection changed the tran-
scriptional response of monocyte progenitors in the BM. At
day 5 post-infection, of the 490 genes assessed, 91 genes had
a greater than 2-fold change (FDR < 0.05) in expression in
cMoPs from naive versus T. gondii-infected animals (Table S1).
Pathway analysis revealed a distinct interferon signature,
marked by increased expression of eight transcriptional regula-
tors, including Stat1, Stat2, and Irf7 (Figure 4B). Furthermore, a
broad suite of anti-microbial factors were increased in expres-
sion, including Gbp2 and Ifi47, intracellular defense factors
critical for resistance to T. gondii infection (Collazo et al., 2001;
Degrandi et al., 2013). In agreement with our flow cytometric
characterization, expression of transcripts for MHCII (H2-Aa,
H2-Ab1, H2-Eb1) and Sca-1 (Ly6a) were increased during infec-
tion, and expression of Cx3cr1 was decreased. These results
reveal that the transcriptional program of monocyte progenitors
during infection can be dramatically altered in the BMprior to ter-
minal differentiation and egress.
Despite these transcriptional changes, cMoPs remained
committed to themonocyte lineage during infection as evidenced
by the sustainedexpressionof Irf8, a transcription factor critical formonocyte development (Figure S3A; Kurotaki et al., 2013), and
lack of expression of transcripts associated with the DC lineage
such as Zbtb46, Flt3, and Id2 (Figure S3B; Merad et al., 2008).
Further, when cultured under monocyte differentiation conditions
(Hettinger et al., 2013), MHCII+Sca-1+ putative cMoPs from
infected mice differentiated into Ly6ChiCD11bhicKit mature
monocytes (Figures S3C and S3D). Likewise, when cultured
under conditions favoring macrophage differentiation (Hettinger
et al., 2013), MHCII+Sca-1+ putative monocytes differentiated
into Ly6CloF4/80hi macrophages (Figures S3E–S3G). These mac-
rophages differentiated from MHCII+Sca-1+ monocytes lacked
expression of MHCII or Sca-1, making them phenotypically iden-
tical to those derived from naive animals (Figure S3F). This sug-
gested that expression of MHCII and Sca-1 required sustained
IFN-g signaling.
Indeed, administration of IFN-g to naive mice was sufficient to
increase expression of MHCII and Sca-1 and decrease expres-
sion of CX3CR1 (Figures 4C, S4A, and S4B). Acquisition of this
phenotype during T. gondii infection was impaired in cells lack-
ing a functional IFN-g receptor (Figures S4C and S4D) and after
IFN-g blockade (Figures 4D, S4E, and S4F). Additionally, treat-
ment with anti-IFN-g abolished the transcriptional program
adopted by cMoPs during infection (Figure S4G). Thus, IFN-g
can directly shape the transcriptional program and function of
monocytes during their development.
NK Cell Production of IFN-g in the BM Educates
Monocyte Progenitors
The extent of cMoP and monocyte education as early as day 5
post-infection and prior to systemic inflammation raised the
possibility that these changes might be triggered by IFN-g pro-
duction in the bone marrow. Indeed, phenotypic alterations to
BMmonocytes during T. gondii infection preceded significant in-
creases in serum levels of IFN-g (Figures 1G and S2B). The BM is
home to mature immune cells capable of producing IFN-g, such
as T cells and innate lymphoid cells (ILCs), including classical NK
cells (Becker et al., 2005; Klose et al., 2014). To identify the early
source of IFN-g in the BM during infection, we tracked the pro-
duction of this cytokine by flow cytometry via direct ex vivo stain-
ing and IFN-g reporter mice (Reinhardt et al., 2009), as well as by
imaging. We found that BM-resident NK cells produce IFN-g as
early as day 4 post-infection (Figures 5A, 5B, and S5A). At this
time point, NK cells were the dominant source of IFN-g in the
BM, with minimal contribution by T cells or type 1 ILCs, and at
day 5, IFN-g production was also observed in T cells (Figures
5B, S5B, and S5C). Histological analysis at day 5 post-infection
found IFN-g-producing NK cells in close proximity to BM mono-
cytes (Figures 5C, 5D, and S5D).
To further assess whether NK cell-derived IFN-g could directly
impact cMoPs, we treated mice with anti-NK1.1 depleting
antibody. This treatment resulted in nearly complete ablation of
the NK compartment in most tissues, and NK cells in the BM
were decreased by approximately 75% (Figure S5E). NK deple-
tion during infection significantly inhibited the early acquisition
of Sca-1 and MHCII by BM cMoPs and Ly6Chi monocytes and
reversed changes to CX3CR1 expression (Figures 5E, S5F,
and S5G). NK depletion also reduced the changes to monocyte
phenotype in the blood, although the effects were less pro-
nounced than on BM populations, suggesting that other sourcesImmunity 42, 1130–1142, June 16, 2015 ª2015 Elsevier Inc. 1133
Figure 2. IFN-g Remodels the Blood Monocyte Compartment
(A and B) CX3CR1-GFPmice were infected intravenously with P. yoelii-infected red blood cells, per-orally with Y. pseudotuberculosis, or per-orally with T. gondii.
(A) Phenotype of blood Ly6Chi monocytes (Mo) after infection with P. yoelli (day 4 p.i.), Y. pseudotuberculosis (day 5 p.i.), and T. gondii (day 8 p.i.).
(legend continued on next page)
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of IFN-g might further educate monocytes outside of the BM
(Figure S5H).
IL-12 Produced by Batf3-Dependent DCs in the MALT
Induces IFN-g Production by BM NK Cells
T. gondii is a potent inducer of IL-12, a cytokine involved in NK
cell activation (Trinchieri, 2003). After infection, a rapid increase
in IL-12p70 was detectable in the blood that coincided with NK
activation in the BM (Figure 6A). Blockade of IL-12 prevented
IFN-g production by BM-resident NK cells and impaired MHCII
and Sca-1 expression by cMoPs and monocytes (Figures 6B,
6C, S6A, and S6B). Early alterations in cMoPs and monocytes
were likewise abolished in IL-12p35-deficient animals, but not
in mice deficient in IL-18, another potent stimulator of IFN-g pro-
duction from NK cells (Figures S6C–S6E; Scharton-Kersten
et al., 1996). Moreover, administration of recombinant IL-12
alone was sufficient to drive IFN-g production by NK cells and
phenotypic alterations to cMoPs and monocytes (Figures 6D,
6E, S6F, and S6G).
We next assessed the tissue and cellular source of IL-12 dur-
ing T. gondii infection. Previous work revealed a dominant role
for Batf3-dependent DCs in IL-12 production during intra-perito-
neal T. gondii infection (Mashayekhi et al., 2011). Consistent with
this, in Batf3-deficient mice that are devoid of CD8a+ lymphoid
resident DCs and migratory CD103+CD11b– DCs (Edelson
et al., 2010; Hildner et al., 2008), IL-12p70 was not increased in
the serum upon oral infection and early NK cell activation was
not detected (Figures 6F–6H and S6H). Furthermore, reduced
NK activation in these mice was associated with impaired acqui-
sition of the Sca-1+MHCII+ phenotype by BM cMoPs and mono-
cytes (Figures 6I and S6I–S6K).
Notably, in contrast to the spleen and BM, the mesLN
compartment produced detectable levels of IL-12p70 post-
infection (Figure 6J). Additionally, transcriptional analysis of
Batf3-dependent DCs in themesLN and spleen revealed a signif-
icant increase in Il12b expression in mesLN DCs but not splenic
DCs post-infection (Figure S6L). Although we cannot completely
exclude the possibility of a transient and discrete contribution of
the BM, our present results, in agreement with previous studies
(Oldenhove et al., 2009; Washino et al., 2012), support the idea
that the MALT is the dominant source of early IL-12 after per-
oral T. gondii infection.
Thus, we propose a model in which mucosal infection can
result in early IL-12 production in the MALT, which acts in a sys-
temic manner to activate NK cells in the BM, resulting in IFN-g
production in this primary hematopoietic tissue. Although we(B) Frequency of blood Ly6Chi monocytes within the total monocyte compartme
(C and D) CX3CR1-GFP mice were administered IFN-g or PBS once per day for
(C) Phenotype of blood Ly6Chi monocytes assessed by flow cytometry.
(D) Frequency of Ly6Chi blood monocytes within the total monocyte compartme
(E and F) CX3CR1-GFP mice were infected with T. gondii and treated with anti-I
(E) Phenotype of blood Ly6Chi monocytes.
(F) Frequency of Ly6Chi monocytes within the total blood monocyte compartmen
(G and H) Chimeric mice comprised of equal numbers of WT CD45.1+ and Ifngr1
(G) Mean fluorescent intensity (MFI) of MHCII and Sca-1 expression by WT and
Values of WT and Ifngr1/ cells from the same host are joined by a line.
(H) Proportion of blood Ly6Chi monocytes in total blood monocytes within WT an
Error bars represent standard deviation. Data are representative of at least two
performed by unpaired Student’s t test or paired t test adjusted for multiple comcannot dismiss a potential role of systemic IFN-g later in this pro-
cess, our findings suggest that early IFN-g-producing NK cells
present in the BM can act as an early alarm system to rapidly
prime Ly6Chi monocytes to respond in a regulatory manner
upon their arrival at barrier sites. Collectively, these data
describe an unexpected role for the local production of IFN-g
in the BM during mucosal infection in altering monocyte function
and reveal that monocyte functional education is a sequential
process in which discrete signals act in defined spatially and
temporally segregated niches.
DISCUSSION
It is often assumed that the tissue microenvironment is largely
responsible for determining the function of recruited cells (Bain
and Mowat, 2014; Ingersoll et al., 2011; Serbina et al., 2008).
Our present work proposes a pre-emptive model in which
discrete signals received during development can also have pro-
found consequences on the subsequent function of myeloid
cells in defined tissue environments. We describe here transcrip-
tional reprogramming of myeloid progenitors in response to
inflammatory factors produced locally in the BM prior to the
onset of a systemic inflammatory response. Our results support
the idea that early sensing of IFN-g (signal 1) by cMoPs in the
BM educates the subsequent function of Ly6Chi monocytes,
particularly their capacity to generate regulatory responses to-
ward products derived from the microbiota (signal 2). Together,
we believe that our present work uncovers a general mecha-
nism of regulation designed to prepare monocytes for recruit-
ment to barrier tissues and prevent aberrant reactivity to the mi-
crobiota that can lead to heightened immunopathology and
tissue damage.
A number of recent studies have noted that upon infection, NK
cells can rapidly become activated and form clusters in close as-
sociation with Ly6Chi monocytes, priming these cells via IFN-g
production and thus enhancing their anti-microbial function
(Coombes et al., 2012; Goldszmid et al., 2012; Kang et al.,
2008). Notably, in each of these cases, the activation of NK cells
was proposed to occur in response to local IL-12 signaling. Here
we show that this activation process can occur in the hematopoi-
etic environment in response to IL-12 emanating from a distal
site of infection. In this setting, IFN-g-producing NK cells
educate monocytes and their progenitors prior to BM egress
and pathogen encounter. Our findings suggest that a previously
unappreciated function ofmature NK cells present in the BM is to
act as a local alarm systemafter infection of barrier sites, shapingnt at time points described in (A).
3 consecutive days.
nt.
FN-g Ab or isotype control (IgG).
t.
/ (CD45.2+) leukocytes were infected or not with T. gondii.
Ifngr1/ blood Ly6Chi monocytes measured by flow cytometry at 8 days p.i.
d Ifngr1/ compartments in naive and infected mice.
independent experiments, n = 3–5 per group. Statistical comparisons were
parisons. **p < 0.01, ***p < 0.001.
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Figure 3. IFN-g Primes BM Monocytes for Regulatory Function during Infection
(A) Ex vivo PGE2 production by Ly6C
himonocytes sorted fromBMof naive or T. gondii-infectedmice at day 5 p.i. and culturedwith or without E. coli lysate, soluble
Toxoplsama antigen (STAg), or various TLR ligands.
(B) Ex vivo PGE2 production by BM Ly6C
hi monocytes sorted from naive or infected mice at day 24 p.i. and stimulated with E. coli lysate.
(C) WT mice were infected as in (A) and treated with anti-IFN-g Ab or isotype control. Ly6Chi monocytes were sorted from BM of naive and infected mice and
assessed ex vivo for PGE2 production in response to E. coli lysate.
(D) Ex vivo PGE2 production by Ly6C
hi monocytes sorted from BM of CX3CR1-GFP mice treated with IFN-g or PBS once per day for 3 consecutive days.
(E) Ex vivo PGE2 production by BM Ly6C
hi monocytes sorted from naiveWTmice, cultured for 6 hr with or without IFN-g, and subsequently stimulated with E. coli
lysate.
(F and G)WTmice were infected as in (A) and BMLy6Chi monocytes were sorted from naive or day 5 infectedmice. Sortedmonocytes were cultured for 6 hr in the
presence or absence of LPS, and gene expression assessed using the NanoString platform.
(legend continued on next page)
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hematopoiesis to favor production of optimally educated
effector cells.
Previously, Batf3-dependent DCs have been implicated in
the development of protective immunity toward T. gondii during
intraperitoneal infection, primarily due to their capacity to make
IL-12 in response to T. gondii-derived ligands (Mashayekhi
et al., 2011). Here, we show that a brief burst of IL-12 production
by this population in the MALT early during infection can activate
NK cells in the BM. These data raise the possibility that one
of the roles of Batf3-dependent DCs in the MALT is to signal
from the barrier to the BM during infection, thereby initiating
the generation of a monocyte primed for regulatory function.
Thus, Batf3-dependent DCs might not only promote the induc-
tion of adaptive Th1 cell immunity, but also control the fate
and function of inflammatory cells during their development via
their capacity to distally control hematopoiesis prior to systemic
inflammation.
Acute primary infection can epigenetically reprogram mono-
cytes, enhancing effector function against subsequent heterolo-
gous infection (Cheng et al., 2014; Quintin et al., 2012), a phe-
nomenon known as ‘‘trained immunity.’’ Intriguingly, we found
that not only did early signals during T. gondii infection modulate
the phenotype and function of monocytes during infection, but
that these changes persisted after resolution of acute inflamma-
tion. In this particular setting of infection, T. gondii establishes a
low-grade chronic infection; therefore, whether the long-term
effects we observe are dependent on the initial BM priming or
low levels of systemic IFN-g remains unclear.
Overall, our findings present a new paradigm for how mono-
cyte fate and function are educated during infection. The critical
roles of IL-12, IFN-g, and bacterial stimuli in classical activation
of macrophages and their anti-microbial function have been
studied for decades, but how the appropriate sequence of
signals leads to coordinated tissue responses has remained
unclear. In particular, our study highlights the highly ordered
temporal nature of these signals and the discrete compartments
in which each of these factors acts. This procession of signals
ultimately results in a balance of inflammatory and regulatory
function by Ly6Chi monocytes upon recruitment to the inflamed
gastrointestinal tract. Further research into how monocyte
development and function are educated to mediate this balance
might provide insight into the role these cells play in perpetuating
inflammation in acute and chronic disease. Moreover, better un-
derstanding of the mechanisms controlling monocyte regulatory
function, and particularly the importance of BM lymphocytes in
early control of this process, might lead to the identification of
novel therapeutic modalities in settings where aberrant mono-
cyte activity has been implicated, such as in inflammatory bowel
diseases (IBDs) and cancer.(F) Principal-component analysis comparing gene expression of untreated and
clustering of samples in a 2-dimensional matrix of principal components 1 and 2
(G) Gene expression of untreated naive monocytes from (F) was compared to e
represent the number of genes altered in expression between that group and unt
more than one group.
(H) Heat maps representing the relative expression of the 30 genes changed onl
Error bars represent standard deviation. Data are representative of two or more in
biological replicates of two pooled samples (H). Statistical comparisonswere perfo
by Welch’s t test adjusted for multiple comparisons (F–H). *p < 0.05, **p < 0.01,EXPERIMENTAL PROCEDURES
Mice
All mice were bred and maintained under pathogen-free conditions at an
American Association for the Accreditation of Laboratory Animal Care-
accredited animal facility at the NIAID and housed in accordance with the pro-
cedures outlined in the Guide for the Care and Use of Laboratory Animals. All
experiments were performed under an animal study proposal approved by the
NIAID Animal Care and Use Committee. Gender- and age-matched mice be-
tween 6 and 14 weeks of age were used. Refer to the Supplemental Experi-
mental Procedures for more information on specific mouse strains.
T. gondii Parasite and Infection Protocol
ME-49 clone C1 of T. gondii (provided by Dr. Michael Grigg, NIAID/NIH) was
obtained by electroporation of the parental ME-49 type II strain (ATCC
50840) with red fluorescent protein (RFP) andwas used for production of tissue
cysts in C57BL/6 mice. Tissue cysts used in experiments were obtained from
female mice that were per-orally inoculated with 10 cysts 2–3 months earlier.
Animals were euthanized and their brains removed and homogenized in 1ml of
PBS (pH 7.2). Cysts were counted on a fluorescent microscope. For experi-
ments, mice were infected by intragastric gavage with ten cysts of ME-49 C1.
Ly6Chi Monocyte and cMoP Purification by FACS
Cell suspensions of naive or T. gondii-infected SILP, blood, or BM were incu-
bated with mixtures of monoclonal antibodies containing anti-FcgRIII/II,
mouse serum, rat IgG (Jackson Immunoresearch), and 7-AAD viability staining
solution (eBioscience) for 15 min on ice. After staining, cell suspensions were
washed, filtered, resuspended in complete medium without phenol red, and
sorted on a BD FACSAria II.
Ex Vivo Stimulation of FACS-Purified Ly6Chi Monocytes for PGE2
Detection
Purified Ly6Chi monocytes were cultured in complete RPMI at a concentration
of 150,000 cells/ml (for monocytes derived from BM) or 30,000 cells/ml (for
monocytes derived from blood) in a 96-well round-bottom tissue culture plate.
In some cases, cells were stimulated with E. coli lysate (1 mg/ml), Soluble
Toxoplasma antigen (STAg) (1 mg/ml), or commercially available TLR ligands
Pam2CSK4 (Invivogen, 500 nM), LPS (Enzo Life Sciences, 500 ng/ml), Flagellin
(Invivogen, 500 ng/ml), CpG (50-TCCATGACGTTCTGAT-30; Integrated DNA
Technologies, 500 nM), or Profilin (Alexis Biochemicals, 500 ng/ml) for 18 hr.
STAg was prepared as previously described (Grunvald et al., 1996). Three to
five replicates of pooled supernatants from four to five mice were assayed
for PGE2 using an enzyme-immunoassay (EIA) (Cayman Chemicals), as per
manufacturers’ instructions. In some experiments, cells were incubated with
20 ng/ml recombinant IFN-g (BioLegend) for 6 hr and washed prior to stimula-
tion with E. coli lysate.
Ex Vivo Stimulation of FACS-Purified Ly6Chi Monocytes for
NanoString Analysis
Ly6Chi monocytes FACS sorted from the BM of uninfected mice or
T. gondii-infected mice at day 5 post-infection were cultured for 6 hr in
complete RPMI at a concentration of 30,000 cells in 100 ml of complete
media in a 96-well v-bottom plate. In some cases, cells were stimulated
with 500 ng/ml LPS (Enzo Life Sciences). After 6 hr, cells were washed
and resuspended at 2,000 cells/ml of RLT buffer (Life Technologies) for
RNA isolation and stored at 80C.LPS-stimulated monocytes from naive and infected mice. Plot represents
.
ach of the other three groups. Numbers in each section of the Venn diagram
reated naive controls, with overlapping regions representing genes changed in
y in monocytes from infected mice upon LPS stimulation.
dependent experiments, n = 3–5 replicates per group (A–E). Columns represent
rmedwith unpaired Student’s t test, adjusted formultiple comparisons (A–E) or
***p < 0.001.
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Figure 4. IFN-g Controls Gene Expression of Monocyte Progenitors Early during Infection
(A) CX3CR1-GFP mice were infected with T. gondii. At defined time points p.i., the phenotype of monocyte progenitors (cMoPs) present in the BMwas assessed
by flow cytometry.
(B) cMoPs were sorted from the BM of naive or day 5 infected mice, and gene expression was assessed by NanoString. Heat maps represent the relative
expression of 37 genes by cMoPs selected by pathway analysis as being affected by IFN-g signaling from naive and infected mice.
(C) CX3CR1-GFP mice were administered 5 mg IFN-g or PBS by i.p. injection once per day for 3 consecutive days. Mice were sacrificed 18 hr after the final
injection, and MHCII and Sca-1 expression by cMoPs was assessed.
(D) CX3CR1-GFP mice were infected and administered anti-IFN-g Ab or isotype control. Expression of MHCII and Sca-1 was assessed at day 5 p.i.
Error bars represent standard deviation. Data are representative of two or more independent experiments, n = 3–5 mice per group (A, C, D). Columns represent
individual samples pooled from three mice (B). Statistical comparisons were performed using one-way ANOVA (A, D), Welch’s t test adjusted for multiple
comparisons (B), or unpaired Student’s t test (C). ***p < 0.001. See also Figures S2–S4.Gene Expression Analysis by NanoString nCounter Technology
The nCounter analysis system (NanoString Technologies) was used to assess
gene expression by cMoPs, BM Ly6Chi monocytes, and various lymphoid-
resident DC populations. In brief, RNA was obtained by lysing the sorted cells1138 Immunity 42, 1130–1142, June 16, 2015 ª2015 Elsevier Inc.(5–10 3 103 cells/5 ml) in RLT buffer (QIAGEN) and then hybridized with the
C2566 Mouse Myeloid Panel. Data analysis was performed according to
NanoString Technology recommendations. For more information, please refer
to the Supplemental Experimental Procedures.
Figure 5. BM NK Cells Educate cMoPs and Ly6Chi Monocytes via IFN-g
(A) WT mice were infected with T. gondii. At defined time points, lymphocyte IFN-g production was assessed by flow cytometry. Plots are gated on
TCR-b–NK1.1+DX5+ NK cells.
(B) Absolute numbers of lymphocytes producing IFN-g in the BM.
(C and D) Confocal images of BM of IFN-g YFP mice at day 5 p.i.
(C) Yellow arrows indicate NK cells producing IFN-g.
(D) Ly6GLy6B2+ monocytes in contact with (yellow arrows) or in close proximity to (orange arrows) NK cells producing IFN-g.
(E) CX3CR1-GFPmice were infected as in (A) and injected intravenously with NK cell depleting antibody (aNK1.1) or isotype control. MHCII and Sca-1 expression
by cMoPs were assessed at day 5 p.i.
Error bars represent standard deviation. Data are representative of two or more independent experiments, n = 3–5 mice per group. Statistical comparisons were
performed using one-way ANOVA. **p < 0.01, ***p < 0.001. See also Figure S5.Intracellular Detection of IFN-g
For ex vivo IFN-g detection, cell suspensions from BM were cultured at 5 3
105–1 3 106 cells/well in 96-well round-bottom plates in the presence of
1 mg/ml brefeldin A (GolgiPlug, BD Biosciences). After 3 hr, cells were stained
for surface markers, then washed twice with FACS buffer and fixed in a solu-
tion of 2%paraformaldehyde (ElectronMicroscopy Sciences). Prior to fixation,
Live/Dead Fixable Blue Cell Stain Kit (Invitrogen) was used to exclude deadcells. Cells were then stained with PE-conjugated antibody against IFN-g
(XMG1.2, eBioscience) or isotype control in the presence of anti-FcgRIII/II re-
ceptor for 60 min on ice in FACS buffer containing 0.5% saponin.
Immunofluorescence Imaging
For immunofluorescence staining of whole-mounted tissues and frozen sec-
tions of BM, we adapted a previously published protocol (Kunisaki et al.,Immunity 42, 1130–1142, June 16, 2015 ª2015 Elsevier Inc. 1139
Figure 6. IL-12 Produced by Batf3-Dependent DCs in the MALT Stimulates NK Cells to Secrete IFN-g
(A) Serum IL-12p70 levels post-infection.
(B and C) WT mice were infected with T. gondii and treated with anti-IL-12p70 Ab or isotype control.
(B) Absolute numbers of IFN-g-producing lymphocytes at day 5 p.i.
(C) MHCII and Sca-1 expression by cMoPs at day 5 p.i.
(D and E) WT mice were administered IL-12 or PBS once per day for 2 days.
(D) Absolute numbers of IFN-g-producing lymphocytes in the BM.
(E) MHCII and Sca-1 expression by cMoPs.
(F) Batf3/ mice and WT controls were infected and CD8a+ and CD11b+ resident DCs in the mesLN were assessed at day 5 p.i. Dot plots are gated on
TCR-b–CD11c+MHCIIint resident DCs. Numbers represent mean frequency of cells gated in this manner ± SD.
(G) Serum IL-12p70 in Batf3/ and WT mice, naive, and day 5 p.i.
(H) Absolute numbers of IFN-g-producing lymphocytes in Batf3/ mice and WT controls at day 5 p.i.
(I) MHCII expression by cMoPs in Batf3/ mice and WT controls at day 5 p.i.
(J) 10% of the total cells from each tissue were cultured for 16 hr and cell supernatants were assessed for IL-12p70.
Error bars represent one standard deviation. Data are representative of two or more independent experiments (A–I) or the pooled results of two independent
experiments (J), n = 3–5 per group. Statistical comparisons were performed using one-way ANOVA or unpaired Student’s t test, corrected for multiple com-
parisons. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S6.2013). Femoral bones were perfused with Periodate-lysine-paraformaldehyde
(PLP) fixation buffer. Post perfusion femurs were fixed for at least 10 hr in PLP-
buffer at 4C, incubated in 30% sucrose overnight, embedded in optical cut-
ting temperature compound (OCT) (Sakura Finetek) over dry ice, and stored
at 80C. Bones were cut on a cryostat until the BM was fully exposed and
then harvested by melting the OCT. Open bones were blocked/permeabilized
with 10% normal rabbit serum, 10% normal mouse serum, 10% Fc-block, and
0.25% Triton X-100 for 2 hr at room temperature, stained with anti-GFP/YFP
(Life Technologies), goat anti-NKp46 (AF2225, R&D Systems), anti-Ly6G
(1A8, BD Biosciences), and anti-Ly6B2 (7/4, AbD Serotec) overnight at 4C1140 Immunity 42, 1130–1142, June 16, 2015 ª2015 Elsevier Inc.while shaking. Bones were then washed with PBS and incubated for 2 hr at
room temperature in secondary antibody AF647 rabbit anti-goat IgG. After
antibody staining, bones were washed and nuclei were stained with DAPI
(Sigma-Aldrich). Stained bone was imaged in a chambered cover glass using
a Leica TCS SP8 confocal microscope. Images were processed with Imaris
Bitplane software.
Ex Vivo Detection of IL-12p70 from Tissue Preparations
MesLN, spleen, and BM were minced and enzymatically digested at 37C for
25 min in complete media (with the exception of FBS, which was excluded)
supplemented with 50 mg/ml liberase TL (Roche) and 0.025% DNase I (Sigma-
Aldrich) to improve extraction of DC populations. After digestion, cell suspen-
sions were generated from these tissues. Ten percent of the total cells from
each tissue were cultured in 25 ml of complete medium for 18 hr and IL-
12p70 was detected in the supernatant by Enhanced Sensitivity Cytometric
Bead Array (BD Biosciences).
Additional procedures can be found in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2015.05.011.
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